Nicacio Leonardo Viana 4
4 · Protara Therapeutics, Inc. · Filed Apr 17, 2025
Insider Transaction Report
Form 4
Nicacio Leonardo Viana
Chief Medical Officer
Transactions
- Award
Common Stock
2025-04-15+50,000→ 52,181 total - Award
Stock Option (Right to Buy)
2025-04-15+150,000→ 150,000 totalExercise: $4.17Exp: 2035-04-14→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of April 15, 2025.
- [F2]25% of the shares vest on the one year anniversary of April 15, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.